In a review of 19 studies, researchers at Johns Hopkins say they can confirm a “strong association” between certain scalp-pulling hairstyles — many common among African-Americans — and the development of traction alopecia, gradual hair loss...
27-Apr-2016 3:10 PM EDT Add to Favorites
Despite Recent Increases in Reported Food Allergy, Study Finds No Change in Antibody Levels Associated with Food Allergy
A new study using 5,000 stored blood samples found no increase in the presence of food-specific immunoglobulin E (IgE) -- a blood marker associated with food allergy -- in children's blood between the 1980s and the 2000s.
25-Apr-2016 3:45 PM EDT Add to Favorites
Studying a new type of pinhead-size, lab-grown brain made with technology first suggested by three high school students, Johns Hopkins researchers have confirmed a key way in which Zika virus causes microcephaly and other damage in fetal brains: by...
18-Apr-2016 3:05 PM EDT Add to Favorites
Results of a multi-institutional national study of nearly 700 people who survived life-threatening illness with a stay in an intensive care unit (ICU) suggest that a substantial majority of them are at high risk for persistent depression, anxiety...
20-Apr-2016 2:40 PM EDT Add to Favorites
In a clinical trial of the immunotherapy drug pembrolizumab, half of 25 patients with a rare type of virus-linked skin cancer called Merkel cell carcinoma experienced substantial tumor shrinkage lasting nearly three times as long, on average, than...
19-Apr-2016 9:35 AM EDT Add to Favorites
Diabetes Drug, Metformin, Lowers Risk of Heart Disease Deaths Better Than Sulfonylureas, New Analysis Shows
A new analysis of 204 studies involving more than 1.4 million people suggests that metformin, the most frequently prescribed stand-alone drug for type 2 diabetes, reduces the relative risk of a patient dying from heart disease by about 30 to 40...
14-Apr-2016 12:20 PM EDT Add to Favorites
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary...
15-Apr-2016 2:45 PM EDT Add to Favorites
In a small, phase I clinical trial, Johns Hopkins Kimmel Cancer Center researchers say they show for the first time that the experimental drug guadecitabine (SGI-110) is safe in combination with the chemotherapy drug irinotecan and may overcome...
15-Apr-2016 3:15 PM EDT Add to Favorites
4-Nov-2015 11:05 AM EST
5-Oct-2015 9:05 AM EDT
24-Apr-2015 9:05 AM EDT
3-Apr-2015 4:05 PM EDT
10-Mar-2015 2:05 PM EDT
2-Mar-2015 2:05 PM EST
12-Dec-2014 1:00 PM EST
6-Oct-2014 10:00 AM EDT